Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18959 | 462 | 28.0 | 70% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
903 | 10618 | DIHYDROPYRIMIDINE DEHYDROGENASE//5 FLUOROURACIL//THYMIDINE PHOSPHORYLASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VASCULAR TOXICITY | Author keyword | 2 | 20% | 2% | 7 |
2 | INTERNAL MED PERIOPERAT ASSESSMENT | Address | 1 | 100% | 0% | 2 |
3 | BOLUS 5 FLUOROURACIL | Author keyword | 1 | 33% | 0% | 2 |
4 | ACTH CORTISOL | Author keyword | 1 | 50% | 0% | 1 |
5 | ASL NOVARA | Address | 1 | 50% | 0% | 1 |
6 | BLEOMYCIN INDUCED PNEUMONITIS | Author keyword | 1 | 50% | 0% | 1 |
7 | CARDIOGENIC SHACK | Author keyword | 1 | 50% | 0% | 1 |
8 | CARDIOSPECIFIC ENZYMES | Author keyword | 1 | 50% | 0% | 1 |
9 | CHEMOTHERAPY INDUCED CARDIOTOXICITY | Author keyword | 1 | 50% | 0% | 1 |
10 | COLON CANCER PATIENTS | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SYMPTOMATIC CARDIOTOXICITY | 26 | 80% | 3% | 16 |
2 | 5 FLUOROURACIL CARDIOTOXICITY | 19 | 70% | 3% | 16 |
3 | ELUSIVE CARDIOPATHY | 17 | 100% | 2% | 8 |
4 | VASCULAR TOXICITY | 12 | 54% | 3% | 15 |
5 | INDUCED CORONARY VASOSPASM | 8 | 100% | 1% | 5 |
6 | FLUOROURACIL CARDIOTOXICITY | 6 | 100% | 1% | 4 |
7 | 5 FLUOROURACIL ASSOCIATED CARDIOTOXICITY | 3 | 100% | 1% | 3 |
8 | MYOCARDIOTOXICITY | 2 | 67% | 0% | 2 |
9 | REVERSIBLE CARDIAC DYSFUNCTION | 2 | 67% | 0% | 2 |
10 | CHEMOTHERAPY TREATMENT | 2 | 27% | 2% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
5-fluorouracil induced cardiotoxicity: Review of the literature | 2012 | 26 | 42 | 93% |
Fluoropyrimidine-associated cardiotoxicity: revisited | 2009 | 39 | 72 | 75% |
Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors | 2013 | 13 | 48 | 71% |
A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity | 2014 | 2 | 72 | 56% |
Alternative Treatment Options in Colorectal Cancer Patients With 5-Fluorouracil- or Capecitabine-Induced Cardiotoxicity | 2013 | 7 | 62 | 37% |
Cardiotoxicity of cancer therapy | 2005 | 115 | 106 | 23% |
Thromboembolic events during chemotherapy for germ cell cancer: A cohort study and review of the literature | 2000 | 104 | 40 | 33% |
5-FLUOROURACIL CARDIOTOXICITY - A CRITICAL-REVIEW | 1990 | 83 | 33 | 70% |
Capecitabine cardiotoxicity - Case reports and literature review | 2008 | 6 | 31 | 81% |
Incidence of ischemic stroke post-chemotherapy: A retrospective review of 10,963 patients | 2006 | 34 | 26 | 35% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTERNAL MED PERIOPERAT ASSESSMENT | 1 | 100% | 0.4% | 2 |
2 | ASL NOVARA | 1 | 50% | 0.2% | 1 |
3 | DIP EMERGENZA | 1 | 50% | 0.2% | 1 |
4 | DISCIPLINAS NEUROL | 1 | 50% | 0.2% | 1 |
5 | EMERGENCY CARDIOL CLIN | 1 | 50% | 0.2% | 1 |
6 | ENDOSCOPY LASER THER Y | 1 | 50% | 0.2% | 1 |
7 | MARY POTTER ONCOL | 1 | 50% | 0.2% | 1 |
8 | ONCOTHER EUT CLIN | 1 | 50% | 0.2% | 1 |
9 | SECTEUR 1 | 1 | 50% | 0.2% | 1 |
10 | SERV MED INTERNE ONCOL MED | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000118177 | EPIDIDYMAL MALAKOPLAKIA//INTRACARDIAC METASTASES//MAGNETIC RESONANCE IMAGING AND ANGIOGRAPHY |
2 | 0.0000105601 | DIHYDROPYRIMIDINE DEHYDROGENASE//DPYD//DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY |
3 | 0.0000092185 | SHIITAKE DERMATITIS//FLAGELLATE DERMATITIS//FLAGELLATE ERYTHEMA |
4 | 0.0000090693 | CANCER PROCOAGULANT//TISSUE FACTOR//CANCER ASSOCIATED THROMBOSIS |
5 | 0.0000086986 | CARDIOTOXICITY//DEXRAZOXANE//DOXORUBICIN |
6 | 0.0000078191 | NONBACTERIAL THROMBOTIC ENDOCARDITIS//MARANTIC ENDOCARDITIS//NON BACTERIAL THROMBOTIC ENDOCARDITIS |
7 | 0.0000068525 | GENITAL GVHD//CARDIAC LATE EFFECTS//HCT HEMATOPOIETIC CELL TRANSPLANTATION |
8 | 0.0000068336 | OXALIPLATIN//CAPECITABINE//IRINOTECAN |
9 | 0.0000068177 | TESTICULAR CANCER//RETROPERITONEAL LYMPH NODE DISSECTION//SEMINOMA |
10 | 0.0000064160 | PULMONARY TOXICITY//PULM DIS INTENS CARE//GEFITINIB IRESSA |